UNSPSC 51332001: Iloperidone

This classification denotes an antipsychotic agent with the molecular formula C24H27FN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VPO7KJ050N, chemically known as 4-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3-methoxyacetophenone but generally known as iloperidone, which bears US NIH Compound Identifier 71360. European Medicines Agency schedules Iloperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08135MIG.

UNSPSC 51332001 Iloperidone is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB60459723LAS — requests Naloxone and Safe Drug Deactivation Systems, which fall outside the scope of iloperidone, an atypical antipsychotic pharmaceutical. The mismatch between the code's nominal scope and the actual procurement suggests either a tagging error in the state and local system or that the code sees minimal relevant activity in public procurement.

Seminole County posted the opportunity on June 30, 2026, with a response deadline of July 26, 2023 (a date that appears inconsistent with the posting date and likely reflects a data entry issue in the source). The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs included in their bid. The contract will run two years with an optional one-year renewal, and vendors must comply with E-Verify requirements, drug-free workplace certification, and insurance coverage including workers' compensation, commercial general liability, and professional liability. FEMA funding may underpin the procurement, introducing additional federal compliance obligations. Given the absence of additional recent opportunities under this code and the clear disconnect between the code name and the solicitation's actual scope, this code shows little relevant activity for pharmaceutical procurement professionals.